Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
66.56
+0.57 (0.86%)
At close: Dec 4, 2025, 4:00 PM EST
66.18
-0.05 (-0.08%)
Pre-market: Dec 5, 2025, 5:23 AM EST
Kymera Therapeutics Employees
Kymera Therapeutics had 188 employees as of December 31, 2024. The number of employees increased by 1 or 0.53% compared to the previous year.
Employees
188
Change (1Y)
1
Growth (1Y)
0.53%
Revenue / Employee
$232,633
Profits / Employee
-$1,569,798
Market Cap
4.79B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 188 | 1 | 0.53% |
| Dec 31, 2023 | 187 | 20 | 11.98% |
| Dec 31, 2022 | 167 | 26 | 18.44% |
| Dec 31, 2021 | 141 | 66 | 88.00% |
| Dec 31, 2020 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KYMR News
- 1 day ago - Kymera Therapeutics, Inc. (KYMR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 10 days ago - Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader - GlobeNewsWire
- 11 days ago - Kymera Therapeutics to Participate in Upcoming December Investor Conferences - GlobeNewsWire
- 24 days ago - Kymera Therapeutics, Inc. (KYMR) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Kymera Therapeutics, Inc. (KYMR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Kymera Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 5 weeks ago - Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025 - GlobeNewsWire
- 5 weeks ago - Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting - GlobeNewsWire